FDA approves dupilumab for atopic dermatitis in teenagers
미 FDA 는 사춘기 아이들의 습진 치료에 dupilumab를 쓸 수 있다고 허가 했다
Reuters (3/11, Mishra, Mathias) reports the Food and Drug Administration approved Dupixent (dupilumab) for the treatment of moderate-to-severe atopic dermatitis in younger patients. The article notes that the drug was previously approved for adults in 2017.